Medina, Miguel
Instituto de Salud Carlos III · Biomedical Research Networking Center on Neurodegenerative Diseases · Fundacion Centro De Investigacion De Enfermedades Neurologicas
13 papers on CoChatORCID 0000-0002-7016-5340
Most cited papers
- Verified
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 2,498
- Verified
What is the evidence that tau pathology spreads through prion-like propagation?
Mudher, A., Colin, M., Dujardin, S., Medina, M., Dewachter, I., Alavi Naini, S. M., Mandelkow, E.-M., Mandelkow, E., Buée, L., Goedert, M., et al. (2017) · Acta Neuropathologica Communications
Alzheimer's disease research and treatmentsPrion Diseases and Protein Misfolding
Cited by 384
- Verified
An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration
Moreno-García, A., Kun, A., Calero, O., Medina, M., & Calero, M. (2018) · Frontiers in Neuroscience
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 372
- Verified
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
del Ser, T., Steinwachs, K. C., Gertz, H. J., Andrés, M. V., Gómez-Carrillo, B., Medina, M., Vericat, J. A., Redondo, P., Fleet, D., & León, T. (2012) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 329
- Verified
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology
Treatment of Major DepressionTryptophan and brain disorders
Cited by 325
- Verified
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I. E., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2021) · Nature Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 324
- Verified
MicroRNAs in Neurodegenerative Diseases
Quinlan, S., Kenny, A., Medina, M., Engel, T., & Jimenez-Mateos, E. M. (2017) · International Review of Cell and Molecular Biology
MicroRNA in disease regulationNeuroinflammation and Neurodegeneration Mechanisms
Cited by 168
- Verified
The role of extracellular Tau in the spreading of neurofibrillary pathology
Medina, M., & Avila, J. (2014) · Frontiers in Cellular Neuroscience
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 161
- Verified
An Overview on the Clinical Development of Tau-Based Therapeutics
Medina, M. (2018) · International Journal of Molecular Sciences
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 156
- Verified
Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment
Fernández-Blázquez, M. A., Ávila-Villanueva, M., Maestú, F., & Medina, M. (2016) · Journal of Alzheimer's Disease
Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies
Cited by 98
- Verified
Modifications of the 5’ untranslated region of foot-and-mouth disease virus after prolonged persistence in cell culture
Escarmís, C., Toja, M., Medina, M., & Domingo, E. (1992) · Virus Research
Animal Disease Management and EpidemiologyRNA and protein synthesis mechanisms
Cited by 77
- Verified
Further understanding of tau phosphorylation: implications for therapy
Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 41
- Verified
Common variants in Alzheimer’s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2019) · medRxiv
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free